AR019737A4 - Composicion antioxidante, citostatica y de energia sostenida que mejora la utilizacion metabolica de glucosa - Google Patents
Composicion antioxidante, citostatica y de energia sostenida que mejora la utilizacion metabolica de glucosaInfo
- Publication number
- AR019737A4 AR019737A4 ARM990103179U ARM990103179U AR019737A4 AR 019737 A4 AR019737 A4 AR 019737A4 AR M990103179 U ARM990103179 U AR M990103179U AR M990103179 U ARM990103179 U AR M990103179U AR 019737 A4 AR019737 A4 AR 019737A4
- Authority
- AR
- Argentina
- Prior art keywords
- cytostatic
- antioxidant
- glucose
- improves
- energy composition
- Prior art date
Links
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title 1
- 239000003963 antioxidant agent Substances 0.000 title 1
- 230000003078 antioxidant effect Effects 0.000 title 1
- 239000000824 cytostatic agent Substances 0.000 title 1
- 230000001085 cytostatic effect Effects 0.000 title 1
- 239000008103 glucose Substances 0.000 title 1
- 230000002503 metabolic effect Effects 0.000 title 1
- 230000002459 sustained effect Effects 0.000 title 1
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 abstract 1
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 abstract 1
- RDHQFKQIGNGIED-MRVPVSSYSA-N O-acetyl-L-carnitine Chemical compound CC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C RDHQFKQIGNGIED-MRVPVSSYSA-N 0.000 abstract 1
- 244000269722 Thea sinensis Species 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000004075 alteration Effects 0.000 abstract 1
- 150000001765 catechin Chemical class 0.000 abstract 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 abstract 1
- 235000005487 catechin Nutrition 0.000 abstract 1
- 235000005911 diet Nutrition 0.000 abstract 1
- 230000000378 dietary effect Effects 0.000 abstract 1
- 235000015872 dietary supplement Nutrition 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940030275 epigallocatechin gallate Drugs 0.000 abstract 1
- 235000009569 green tea Nutrition 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Botany (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Neurosurgery (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Una composicion para la prevencion y/o tratamiento terapéutico de varias alteraciones y estados patologicos inducidos por radicales libres que pueden tenerla forma de un suplemento dietético, un soporte dietético o de un medicamento real, que comprenden como ingredientes activos caracterizantes acetil L-carnitinay por lo menos una de las catequinas (galato de epigalocatequina) que pueden extraerse del te verde.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT98RM000433A IT1299197B1 (it) | 1998-06-30 | 1998-06-30 | Composizione ad attivita' antiossidante, antiproliferativa, energetica e atta a migliorare l'utilizzazione metabolica del glucosio. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR019737A4 true AR019737A4 (es) | 2002-03-13 |
Family
ID=11406017
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARM990103179U AR019737A4 (es) | 1998-06-30 | 1999-06-30 | Composicion antioxidante, citostatica y de energia sostenida que mejora la utilizacion metabolica de glucosa |
Country Status (5)
| Country | Link |
|---|---|
| AR (1) | AR019737A4 (es) |
| AU (1) | AU4391199A (es) |
| IT (1) | IT1299197B1 (es) |
| TN (1) | TNSN99138A1 (es) |
| WO (1) | WO2000000183A2 (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1316997B1 (it) * | 2000-03-02 | 2003-05-26 | Sigma Tau Healthscience Spa | Composizione per la prevenzione e/o il trattamento di vasculopatie,che comprende propionil l-carnitina e coenzima q10. |
| IT1317036B1 (it) * | 2000-05-30 | 2003-05-26 | Sigma Tau Healthscience Spa | Integratore ad attivita' antiossidante comprendente unaalcanoilcarnitina ed una associazione di polifenoli estratti da piante |
| IT1317035B1 (it) * | 2000-05-30 | 2003-05-26 | Sigma Tau Healthscience Spa | Integratore ad attivita' antiossidante comprendente unaalcanoilcarnitina ed una associazione di polifenoli estratti dal |
| US6923960B2 (en) | 2001-10-03 | 2005-08-02 | Vsl Pharmaceuticals Inc. | Antioxidant combination composition and use thereof |
| JP2005533864A (ja) * | 2002-07-26 | 2005-11-10 | ディーエスエム アイピー アセッツ ビー．ブイ． | ラクトフェリンを含む組成物 |
| JP2006506361A (ja) * | 2002-10-11 | 2006-02-23 | クレアグリ， インコーポレイテッド | カルニチンおよび酸化防止ポリフェノールの治療用組合せ |
| JP2005089384A (ja) * | 2003-09-18 | 2005-04-07 | Kao Corp | 持久力向上剤 |
| US7205011B2 (en) | 2003-11-14 | 2007-04-17 | Board Of Regents, Acting For And On Behalf Of, University Of Arizona | Anti-inflammatory activity of a specific turmeric extract |
| US8012513B2 (en) * | 2006-06-08 | 2011-09-06 | The Procter & Gamble Company | Method for promoting eye health |
| AU2007273955B2 (en) * | 2006-06-08 | 2012-09-06 | Mars, Incorporated | Composition for improving eye health |
| US9579347B2 (en) | 2012-10-04 | 2017-02-28 | Abbott Laboratories | Methods for enhancing the effect of EGCg on mitigating skeletal muscle loss |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU518617B2 (en) * | 1977-04-29 | 1981-10-08 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Therapeutic application of acetyl-d, 1-carnitine |
| WO1997002041A1 (en) * | 1995-07-03 | 1997-01-23 | Crandall Wilson T | Transdermal and oral treatment of androgenic alopecia |
| IT1276225B1 (it) * | 1995-10-17 | 1997-10-27 | Sigma Tau Ind Farmaceuti | Composizioni farmaceutiche contenenti l-carnitina e alcanoil l- carnitine in associazione con resveratrolo o suoi derivati utili per |
| US5667791A (en) * | 1996-05-31 | 1997-09-16 | Thione International, Inc. | X-ray induced skin damage protective composition |
| WO1998033494A1 (en) * | 1997-02-04 | 1998-08-06 | Kosbab John V | Compositions and methods for prevention and treatment of vascular degenerative diseases |
-
1998
- 1998-06-30 IT IT98RM000433A patent/IT1299197B1/it active IP Right Grant
-
1999
- 1999-06-17 AU AU43911/99A patent/AU4391199A/en not_active Abandoned
- 1999-06-17 WO PCT/IT1999/000176 patent/WO2000000183A2/en active Application Filing
- 1999-06-30 AR ARM990103179U patent/AR019737A4/es unknown
- 1999-06-30 TN TNTNSN99138A patent/TNSN99138A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IT1299197B1 (it) | 2000-02-29 |
| WO2000000183A3 (en) | 2000-06-29 |
| AU4391199A (en) | 2000-01-17 |
| TNSN99138A1 (fr) | 2005-11-10 |
| ITRM980433A1 (it) | 1999-12-30 |
| WO2000000183A2 (en) | 2000-01-06 |
| ITRM980433A0 (it) | 1998-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR022076A1 (es) | Composicion antioxidante constituida por acetil l-carnitina y acido alfa-lipoico para mejorar el aprovechamiento metabolico de la glucosa | |
| BRPI0506305A (pt) | artigos e métodos de tratamento da pele | |
| AR027355A1 (es) | Acidos tiazolidincarboxilicos | |
| AR054939A1 (es) | Metodos para aplicar formulaciones antimicrobianas sobre alimentos | |
| AR035637A1 (es) | Betamimeticos de larga accion, procedimiento para su preparacion y su empleo como medicamentos | |
| BR0302672A (pt) | Formulação farmacêutica nutriente compreendendo polifenóis e seus usos no tratamento de câncer | |
| DE10085007T1 (de) | Antiinfektionszusammensetzungen zur Behandlung von erkranktem Gewebe, wie Lippenherpes | |
| AR019737A4 (es) | Composicion antioxidante, citostatica y de energia sostenida que mejora la utilizacion metabolica de glucosa | |
| WO2002034072A3 (en) | Synergistic antioxidant combination of delta tocols and polyphenols | |
| WO2006131737A3 (en) | Method and composition for treating inflammatory disorders | |
| BRPI0415758A (pt) | combinações de substáncias ativas fungicidas sinergìsticas | |
| UY29876A1 (es) | Derivados de acidos dicarboxilicos y su uso | |
| ECSP066378A (es) | "un derivado de isoxazolina como un inhibidor contra varias caspasas, un procedimiento para preparar el mismo y una composicion terapeutica para prevenir la inflamacion y la apotosis que comprende el mismo" | |
| AR035567A1 (es) | Composiciones que comprenden bloqueadores de transferencia de celula renal l-dopa para el tratamiento de la enfermedad de parkinson | |
| MXPA06013121A (es) | Metodo y composicion para el tratamiento de rinitis. | |
| AR028959A1 (es) | Uso de rapamicina para la manufactura de un medicamento para tratar enfermedades cardiovasculares | |
| BR0209327A (pt) | Composição para tratamento de constipação induzida por drogas | |
| AR053780A1 (es) | Uso de mirtazapina s para la fabricacion de un medicamento para el tratamiento de los bochornos | |
| UY29723A1 (es) | Uso de arilanilidas para tratamiento de semillas | |
| AR023391A1 (es) | Composicion que contiene carnitina e inositol fosfato, util como suplemento dietario o droga | |
| AR024564A1 (es) | Composicion que comprende esfingomielinasa para el uso como una preparacion dietetica, suplemento dietario o producto farmaceutico | |
| FR2887150B1 (fr) | Composition pharmaceutique comprenant un elastomere organopolysiloxane et un principe actif solubilise | |
| BR0315942A (pt) | Tratamento de doenças e condições mediadas pelo aumento de fosforilação | |
| ES2195939T3 (es) | Composicion para prevencion y/o tratamiento de trastornos circulatorios que comprende derivados de l-carnitina y extractos de ginkgo biloba. | |
| WO2002067971A3 (en) | Use of endostatin in the treatment of ocular neovascularization |